ASMB: Assembly Biosciences, Inc. Stock

by  •  • Comments Off on ASMB: Assembly Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 75.07
Enterprise Value ($M) 36.73
Book Value ($M) 33.36
Book Value / Share 4.45
Price / Book 2.25
NCAV ($M) 29.69
NCAV / Share 3.96
Price / NCAV 2.53

Profitability (mra)
Return on Invested Capital (ROIC) -1.10
Return on Assets (ROA) -0.34
Return on Equity (ROE) -1.23

Liquidity (mrq)
Quick Ratio 2.42
Current Ratio 2.42

Balance Sheet (mrq) ($M)
Current Assets 115.50
Assets 119.17
Liabilities 85.81
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 28.52
Operating Income -45.42
Net Income -40.18
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -51.12
Cash from Investing 40.17
Cash from Financing 29.45

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 4.99 -10.71
12-23 13G Schornstein Alexander 9.99 6.43
06-20 13D/A Gilead Sciences Inc 19.99 -90.29

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 1,379 7,122 19.36
2025-04-16 2,260 8,302 27.22
2025-04-15 6,021 16,313 36.91
2025-04-14 2,850 18,877 15.10

(click for more detail)

Similar Companies
ARQT – Arcutis Biotherapeutics, Inc. ARVN – Arvinas, Inc.
ARWR – Arrowhead Pharmaceuticals, Inc. ATRA – Atara Biotherapeutics, Inc.
AVIR – Atea Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io